Vanda Pharmaceuticals (VM4.F) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.18
-0.1
-0.03
0.05

Details

Expected EPS
-0.10197045199
Actual EPS
-0.0764776
Surprise EPS
0.03
Surprise Percent
+25%

Description

Vanda Pharmaceuticals (VM4.F) has reported earnings of -0.0764776 per share for Q1 2025.

0 Comments

Share your thoughts